Wasatch Advisors LP Acquires 448,360 Shares of Pediatrix Medical Group, Inc. $MD

Posted by on Aug 12th, 2026

Wasatch Advisors LP lifted its holdings in Pediatrix Medical Group, Inc. (NYSE:MD – Free Report) by 21.9% in the 2nd quarter, Holdings Channel reports. The firm owned 2,498,884 shares of the company’s stock after acquiring an additional 448,360 shares during the period. Wasatch Advisors LP’s holdings in Pediatrix Medical Group were worth $63,297,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of MD. Global Retirement Partners LLC increased its holdings in Pediatrix Medical Group by 68,250.0% in the 4th quarter. Global Retirement Partners LLC now owns 1,367 shares of the company’s stock worth $29,000 after buying an additional 1,365 shares in the last quarter. Transamerica Financial Advisors LLC purchased a new position in Pediatrix Medical Group in the 4th quarter worth about $30,000. Eurizon Capital SGR S.p.A. bought a new position in Pediatrix Medical Group during the 4th quarter valued at about $33,000. TD Private Client Wealth LLC bought a new position in Pediatrix Medical Group during the 4th quarter valued at about $39,000. Finally, Los Angeles Capital Management LLC purchased a new stake in shares of Pediatrix Medical Group during the 4th quarter valued at about $43,000. 97.71% of the stock is owned by institutional investors.

Pediatrix Medical Group Stock Performance

MD opened at $26.20 on Wednesday. The company’s 50 day moving average is $25.24 and its 200 day moving average is $22.69. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.45. The company has a market cap of $2.13 billion, a price-to-earnings ratio of 12.54 and a beta of 0.66. Pediatrix Medical Group, Inc. has a 12-month low of $14.19 and a 12-month high of $27.94.

Pediatrix Medical Group (NYSE:MD – Get Free Report) last announced its earnings results on Tuesday, August 4th. The company reported $0.63 EPS for the quarter, beating analysts’ consensus estimates of $0.59 by $0.04. The business had revenue of $487.78 million during the quarter, compared to analysts’ expectations of $478.49 million. Pediatrix Medical Group had a net margin of 8.96% and a return on equity of 20.05%. The firm’s revenue was up 4.1% on a year-over-year basis. During the same period in the prior year, the company earned $0.53 earnings per share. On average, equities research analysts predict that Pediatrix Medical Group, Inc. will post 2.13 EPS for the current year.

Analyst Ratings Changes

A number of brokerages have recently commented on MD. Mizuho set a $24.00 price target on shares of Pediatrix Medical Group in a research note on Friday, May 8th. Jefferies Financial Group restated a “buy” rating and set a $27.00 price objective on shares of Pediatrix Medical Group in a research report on Monday, April 20th. Truist Financial raised their target price on shares of Pediatrix Medical Group from $23.00 to $28.00 and gave the stock a “hold” rating in a report on Tuesday, July 14th. Weiss Ratings raised shares of Pediatrix Medical Group from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Tuesday, August 4th. Finally, Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a $25.00 target price on shares of Pediatrix Medical Group in a research note on Wednesday, August 5th. Two research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat, Pediatrix Medical Group has an average rating of “Hold” and an average price target of $24.83.

Check Out Our Latest Report on MD

Pediatrix Medical Group Company Profile

(Free Report)

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.

Featured Articles

Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pediatrix Medical Group, Inc. (NYSE:MD – Free Report).

Institutional Ownership by Quarter for Pediatrix Medical Group (NYSE:MD)

Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.